GLP-1 receptor agonist use during immune checkpoint inhibitor therapy is associated with mortality and Immune-Related adverse events across cancer types in People with type 2 Diabetes: A Target-Trial emulation

GLP-1 RA use during ICI therapy correlated with lower mortality, reduced acute care, fewer irAEs; ophthalmic signals warrant monitoring.

Authors

Institutions

Publication Details

Journal
Diabetes Research and Clinical Practice
Published
2025-12-25
DOI
https://doi.org/10.1016/j.diabres.2025.113073
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GLP-1 receptor agonist use during immune checkpoint inhibitor therapy is associated with mortality and Immune-Related adverse events across cancer types in People with type 2 Diabetes: A Target-Trial emulation

Pin-Hung Li, Yu-Fang Lin, Pei-Yun Li, Jia-Yuh Chen et al.
Diabetes Research and Clinical Practice
Diabetes Treatment and Management
article

GLP-1 receptor agonist use during immune checkpoint inhibitor therapy is associated with mortality and Immune-Related adverse events across cancer types in People with type 2 Diabetes: A Target-Trial emulation

Pin-Hung Li, Yu-Fang Lin, Pei-Yun Li, Jia-Yuh Chen, Shan-Ho Chan, Wei-Hsun Wang, Yu-Nan Huang
article en

Abstract

GLP-1 RA use during ICI therapy correlated with lower mortality, reduced acute care, fewer irAEs; ophthalmic signals warrant monitoring.

Diabetes Research and Clinical PracticeVol. 231
Kaohsiung Medical University (TW), Taipei Tzu Chi Hospital (TW), Chung Shan Medical University Hospital (TW), Changhua Christian Hospital (TW), Chung Shan Medical University (TW)
Chung Shan Medical University, Chung Shan Medical University Hospital
Good health and well-being
Openalex Percentile: Top 30%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GLP-1 receptor agonist use during immune checkpoint inhibitor therapy is associated with mortality and Immune-Related adverse events across cancer types in People with type 2 Diabetes: A Target-Trial emulation — Pin-Hung Li, Yu-Fang Lin, et al. · Diabetes Research and Clinical Practice (2025) | TGRS Research Map | TGRS